Sign inGet started

AUERBACH MARK

Insider CIK 1018007 · OPTR Director · VTUS Director · RCAP Director · PRDS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PRDS PARDES BIOSCIENCES, INC. D To issuer deriv2023-08-312023-08-3137,500— $00SEC↗
PRDS PARDES BIOSCIENCES, INC. D To issuer deriv2023-08-312023-08-3175,000— $00SEC↗
PRDS PARDES BIOSCIENCES, INC. D To issuer deriv2023-08-312023-08-3137,500— $00SEC↗
PRDS PARDES BIOSCIENCES, INC. U Tender2023-08-312023-08-3170,390— $00SEC↗
PRDS PARDES BIOSCIENCES, INC. A Award deriv2023-06-012023-06-0237,500— $037,500SEC↗
PRDS PARDES BIOSCIENCES, INC. A Award deriv2022-06-082022-06-1037,500— $037,500SEC↗
PRDS PARDES BIOSCIENCES, INC. A Award deriv2021-12-232021-12-2875,000— $075,000SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2019-05-172019-05-1710,000— $010,000SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2018-05-302018-06-017,500— $07,500SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2017-06-012017-06-057,500— $07,500SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2016-06-022016-06-0310,000— $010,000SEC↗
RCAP RCS Capital Corp D To issuer2015-12-182015-12-284,424$11.30 $50.0K123,537SEC↗
RCAP RCS Capital Corp D To issuer2015-12-182015-12-286,637$11.30 $75.0K116,900SEC↗
RCAP RCS Capital Corp D To issuer2015-12-182015-12-281,070$11.21 $12.0K115,830SEC↗
RCAP RCS Capital Corp D To issuer2015-12-182015-12-283,791$11.21 $42.5K112,039SEC↗
RCAP RCS Capital Corp D To issuer2015-12-182015-12-284,424$11.30 $50.0K127,961SEC↗
RCAP RCS Capital Corp A Award2015-08-182015-08-2899,206$2.52 $250.0K132,385SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2015-05-282015-06-0110,000— $010,000SEC↗
RCAP RCS Capital Corp A Award2015-01-132015-01-204,424$11.30 $50.0K21,681SEC↗
RCAP RCS Capital Corp A Award2015-01-132015-01-204,424$11.30 $50.0K17,257SEC↗
RCAP RCS Capital Corp A Award2015-01-132015-01-201,070$11.21 $12.0K29,388SEC↗
RCAP RCS Capital Corp A Award2015-01-132015-01-206,637$11.30 $75.0K28,318SEC↗
RCAP RCS Capital Corp A Award2015-01-132015-01-203,791$11.21 $42.5K33,179SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2014-07-102015-04-1564,000— $064,000SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. A Award deriv2014-07-102014-10-0764,000— $064,000SEC↗
VTUS ASSEMBLY BIOSCIENCES, INC. D To issuer deriv2014-07-102014-07-147,000— $00SEC↗
VTUS ASSEMBLY BIOSCIENCES, INC. D To issuer deriv2014-07-102014-07-142,000— $00SEC↗
VTUS ASSEMBLY BIOSCIENCES, INC. A Award deriv2014-07-102014-07-1464,000— $064,000SEC↗
VTUS ASSEMBLY BIOSCIENCES, INC. D To issuer deriv2014-07-102014-07-142,000— $00SEC↗
RCAP RCS Capital Corp A Award2014-06-092014-06-091,429$29.74 $42.5K12,429SEC↗
RCAP RCS Capital Corp A Award2014-06-092014-06-09404$29.74 $12.0K12,833SEC↗
RCAP RCS Capital Corp A Award2014-06-092014-06-0910,000$21.00 $210.0K11,000SEC↗
RCAP RCS Capital Corp P Buy2014-06-052014-06-091,000$20.20 $20.2K1,000SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer deriv2013-10-242013-10-283,461$10.61 $36.7K0SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer deriv2013-10-242013-10-285,000$5.68 $28.4K0SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer deriv2013-10-242013-10-2810,000$3.22 $32.2K0SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer deriv2013-10-242013-10-285,000$2.03 $10.1K0SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer deriv2013-10-242013-10-2810,000$0.93 $9.3K0SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer2013-10-242013-10-2810,000$10.75 $107.5K10,000SEC↗
OPTR OPTIMER PHARMACEUTICALS IN D To issuer2013-10-242013-10-2810,000$10.75 $107.5K0SEC↗
VTUS VENTRUS BIOSCIENCES INC A Award deriv2013-03-062013-03-0810,000— $010,000SEC↗
OPTR OPTIMER PHARMACEUTICALS IN A Award2013-02-262013-02-282,500— $020,000SEC↗
OPTR OPTIMER PHARMACEUTICALS IN A Award2013-01-012013-01-037,500— $017,500SEC↗
OPTR OPTIMER PHARMACEUTICALS IN A Award2012-05-312012-06-202,500— $010,000SEC↗
OPTR OPTIMER PHARMACEUTICALS IN A Award2012-01-012012-01-035,000— $07,500SEC↗